QA: Abbvie Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2021_Abbvie_Inc.pdf

Logs

Graph

Absolute values for 0001551152, Abbvie Inc

  xvar xval
0 AssetsCurrent 24,173,000,000
1 IntangibleAssetsNetIncludingGoodwill 116,000,000,000
2 PropertyPlantAndEquipmentNet 5,248,000,000
3 remainder_Assets 5,144,000,000
4 LiabilitiesCurrent 28,661,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 14,844,335,573
8 SellingGeneralAndAdministrativeExpense 12,456,904,000
9 ResearchAndDevelopmentExpense 7,509,872,903
10 remainder_Expenses -1,166,571,253
11 remainder_Revenues 48,075,329,565
12 remainder_NetIncome -14,814,627,183
13 remainder_ComprehensiveNetIncome -276,438,579
  yvar yval
0 Assets 150,565,000,000
1 Liabilities 28,661,000,000
2 Expenses 33,644,541,223
3 Revenues 48,075,329,565
4 StockholdersEquity 121,904,000,000
5 NetIncome -383,838,841
6 ComprehensiveNetIncome -522,058,130
7 BaseVar 138,018,468,275
8 EconomicCapitalRatiobeforeLimitedLiability 2.96
9 EconomicCapitalRatio 3.66

Edgar->Model Mapping

Feature Distribution

Change over Time